drugset / Trial / NCT06692647

A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)

NCT06692647

Phase 1 Completed 19 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to learn what happens to MK-4318 in a person's body over time. Researchers will compare what happens to levels of MK-4318 in people's blood when it is taken with and without diltiazem. Researchers also want to learn about the safety of MK-4318 taken with and without diltiazem and if people tolerate them.

Timeline

Start
2024-02-09
Primary completion
2024-04-11
Completion
2024-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule Oral
Subject MK-4318 Unknown Oral

Indications

No indication recorded.